Abdurrahman Acar

Abdurrahman Acar

Auto-generated profile, based on publicly available information

Abdurrahman Acar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2023 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
SÇSever Çağlar
Sever Çağlar
MDMustafa Fatih Daşcı
Mustafa Fatih Daşcı
AAAbdurrahman Acar
Abdurrahman Acar
AÇAysel Çağlar
Aysel Çağlar
YDYaşar Mahsut DİNÇEL
Yaşar Mahsut DİNÇEL
AÇAziz Çataltepe
Aziz Çataltepe
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

11 June 2021 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
TATolgahan Atcı
Tolgahan Atcı
EAEnder Alagöz
Ender Alagöz
ESElif Yaprak Saraç
Elif Yaprak Saraç
HÖHakan Özbay
Hakan Özbay
MDMustafa Fatih Daşcı
Mustafa Fatih Daşcı
MGMehmet Akif Güleç
Mehmet Akif Güleç
Objectives: We aimed to investigate the radiological, biomechanical, histopathological, histomorphometric, and immunohistochemical effects of different doses of vardenafil on fracture healing. Materials and methods: Fifty-one rats were divided into three groups. Group V5 was given 5 mg/kg/day of vardenafil; Group V10 was given 10 mg/kg/day of vardenafil; and the control group was given the same volume of saline. Six rats from each group were sacrificed on Day 14 (early period) and the remaining rats were sacrificed on Day 42 (late period). Callus/femoral volume and bone mineral density were measured using micro- computed tomography. Five femurs from each group in the late period were examined by biomechanical tests. In addition to the histopathological and histomorphometric evaluations, immunohistochemical analyses were performed to examine the levels of inducible nitric oxide synthase (iNOS), transforming growth factor-3 (TGF-β3), and nuclear factor kappa B (NF-κB) proteins. Results: Both doses of vardenafil increased primary bone volume and maximal bone fracture strength in late period, compared to the control group (p^lt;0.05). Histological healing scores of vardenafil groups were significantly higher in early period (p<0.001). While cartilaginous callus/total callus ratio in early period was higher, callus diameter/femoral diameter ratio in late period was lower in vardenafil groups (p<0.01). The NF-κB immunopositivity in V10 group decreased in early period, compared to control group (p<0.001). The TGF-β3 and iNOS immunopositivity increased in both V5 and V10 groups, compared to the control group in early period, but returned to normal in late period. Conclusion: During the first period of fracture healing process in which vasodilation is mostly required with increasing inflammation, vardenafil has ameliorating effects on the bone union and supports fracture healing.

21 October 2022 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
MDMustafa Fatih Dasci
Mustafa Fatih Dasci
ESElif Yaprak Sarac
Elif Yaprak Sarac
AYAsiye YURTTAŞ
Asiye YURTTAŞ
TATolgahan Atci
Tolgahan Atci
MUMuhammed Uslu
Muhammed Uslu
EAEnder Alagoz
Ender Alagoz
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

22 October 2026 in Medicina
Verified
Journal Article
Open access
PDF file
OBOzancan Biçer
Ozancan Biçer
MAMehmet Laçin Atli
Mehmet Laçin Atli
AAAbdurrahman Acar
Abdurrahman Acar
MUMuhammed Uslu
Muhammed Uslu
YGYigit Guleryuz
Yigit Guleryuz
OAOktay ADANIR
Oktay ADANIR
Background and Objectives: Serum albumin has been widely studied as a prognostic marker after geriatric hip fracture, whereas less is known about total protein and the additional prognostic information provided by these markers beyond routine clinical factors. This study examined the associations of preoperative albumin and total protein with one-year mortality in older patients with intertrochanteric femur fractures treated with proximal femoral nailing and assessed whether these markers improved mortality prediction when added to routinely available clinical and laboratory variables. Materials and Methods: This retrospective cohort study included 317 patients aged ≥65 years who underwent proximal femoral nailing for intertrochanteric femur fractures. Clinical variables and admission laboratory parameters, including hemoglobin, creatinine, neutrophil and lymphocyte counts, neutrophil-to-lymphocyte ratio, albumin, and total protein, were evaluated. The primary outcome was all-cause mortality within one year after surgery. Multivariable logistic regression was used to identify factors independently associated with mortality. The additional prognostic value of albumin and total protein was assessed by changes in the area under the receiver operating characteristic curve (AUC) and likelihood-ratio tests. Results: Among 317 patients, 133 (42.0%) died within one year. Age (adjusted odds ratio [aOR] 1.14 per year, 95% CI 1.09–1.19; p < 0.001), ASA class III (aOR 4.71, 95% CI 1.27–17.47; p = 0.021), time to surgery (aOR 1.27 per day, 95% CI 1.12–1.44; p < 0.001), and log-transformed creatinine (aOR 3.56 per e-fold increase, 95% CI 1.89–6.69; p < 0.001) were independently associated with one-year mortality. Albumin was lower among patients who died (median 3.60 vs. 3.80 g/dL; p = 0.009), but its adjusted association with mortality was not statistically significant and was imprecisely estimated (aOR 0.78, 95% CI 0.37–1.64; p = 0.506). Total protein was also not independently associated with mortality (aOR 1.11, 95% CI 0.68–1.82; p = 0.681). The base clinical model had an AUC of 0.809 (95% CI 0.761–0.854), compared with 0.810 (95% CI 0.764–0.855) after addition of albumin and total protein (ΔAUC = 0.0013, 95% CI −0.0029 to 0.0058; likelihood-ratio p = 0.801). Conclusions: Age, ASA class, time to surgery, and renal function were independently associated with one-year mortality. Although lower preoperative albumin was associated with mortality in unadjusted analysis, its adjusted association was not statistically significant and was imprecisely estimated. In this cohort, there was no clear evidence that adding albumin and total protein provided incremental prognostic value beyond the base clinical model.

12 June 2026 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
MUMuhammed Uslu
Muhammed Uslu
OBOzancan Biçer
Ozancan Biçer
YÖYiğit Önaloğlu
Yiğit Önaloğlu
EBEmin Can Balcı
Emin Can Balcı
YGYigit Guleryuz
Yigit Guleryuz
EAEnder Alagöz
Ender Alagöz
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

30 June 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
OAOktay ADANIR
Oktay ADANIR
OBOzancan Biçer
Ozancan Biçer
YGYigit Guleryuz
Yigit Guleryuz
MUMuhammed Uslu
Muhammed Uslu
AAAbdurrahman Acar
Abdurrahman Acar
BBBusra Yaprak Bayrak
Busra Yaprak Bayrak
Background: Tranilast is an anti-inflammatory and antifibrotic agent known to inhibit TGF-β-mediated fibroblast activation and matrix overproduction. Although its therapeutic potential has been explored in several fibrotic and inflammatory conditions, its effects on tendon healing remain unknown. This study aimed to evaluate the histopathological and biomechanical impact of tranilast in a rat Achilles tendon repair model. Methods: Thirty-two male Sprague–Dawley rats were randomly assigned to four subgroups, control (C-15, C-30) and tranilast-treated (TR-15, TR-30), and sacrificed on postoperative day 15 or 30. Tranilast (30 mg/kg/day) or placebo was administered intraperitoneally. Tendons were subjected to biomechanical testing (maximum load to failure) and histological evaluation using Bonar and Movin scoring systems on Hematoxylin + Eosin (HE)-, Masson Trichrome (MT)- and Alcian Blue (AB)-stained slides. Additional analyses included Sirius Red histochemistry with assessment of collagen type I/III intensity and polarization ratio, as well as H-scores for collagen I and III. Results: Tranilast produced marked improvements in histopathological healing. Both TR-15 and TR-30 exhibited significantly lower Bonar and Movin scores compared with controls, with reductions in tenocyte degeneration, ground-substance accumulation, collagen disorganization, vascularity, and hyalinization (all p < 0.01). However, biomechanical strength did not differ significantly among the groups (p = 0.3948). Sirius Red analysis and collagen I/III H-scores revealed no significant differences in collagen composition or polarization ratio. Histological improvements were therefore not accompanied by measurable changes in collagen subtype distribution or maximum load to failure. Conclusions: Tranilast was associated with favorable histopathological changes during Achilles tendon healing, including improvements in cellular morphology, matrix organization, and overall Bonar and Movin scores. However, these findings were not accompanied by significant differences in collagen composition or biomechanical strength within the 30-day observation period. Further long-term and mechanistic studies are warranted to determine whether these histopathological changes translate into functional improvements in tendon biomechanics. Accordingly, the present findings should be considered preliminary and exploratory.